Blood immune markers after lung nodule surgery
Part of Cancer, Lungs & breathing clinical trials.
This study collects small blood samples from patients who've had lung nodule surgery to understand how the immune system changes after the operation. Researchers will use advanced lab techniques to detect immune patterns that may help predict or explain why multiple lung nodules develop.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Had surgery to remove a primary lung nodule and have remaining lung nodules or need follow-up monitoring
- Plan to receive routine follow-up care at the hospital running this study
- Able to give an extra small blood sample during your routine postoperative blood draws
- Able to understand the study and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study collects small blood samples from people who have had lung surgery for nodules (small growths) to understand how the immune system responds after surgery. The goal is to learn more about what happens when multiple nodules remain after one is removed.
This study is collecting blood samples from people with lung nodules to help design a better test for lung cancer. It may help find cancer earlier without invasive procedures.
This study looks at changes in small molecules, genetic material, and other markers in the blood before and after lung cancer surgery. The goal is to develop a simple blood test to monitor patients over time and see if the cancer comes back.
This trial looks at how your immune system markers might help predict your outlook after lung cancer surgery. It aims to see if certain immune signals can guide future treatment planning.
This trial uses a simple blood test to look at certain genetic markers that may help doctors decide if a lung nodule is cancerous or not. It is designed for people who have a lung nodule that needs further testing like a biopsy or surgery.
This study uses advanced testing methods on lung nodules to better tell if they are benign (not cancer) or malignant (cancer). It may help improve diagnosis for people scheduled for surgery to remove a lung nodule.
Hear when a new Multiple Pulmonary Nodules trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.